Arion banki hf (ARION-SDB)
Stockholm Exchange · Sweden · prices in SEK · close of 23 Oct 2026
Key indicators
| Last close | SEK 14.48 |
|---|---|
| 52-week range | 12.60 – 15.78 |
| Return, 1 month / 3 months | −1.1% / −3.2% |
| Return, 1 year / 3 years | +3.4% / +39.0% |
| Trend | Below its 200-day average |
| RSI (14) | 51 |
| Volatility (1 year) | 20.8% |
| Worst drawdown (1 year) | -13.4% |
| Average daily value traded | 0.34M SEK |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Arion banki is an Icelandic commercial bank based in Reykjavik. It provides banking services to individuals, businesses and institutional clients, including deposit accounts, lending, mortgages, savings products, asset management and advisory services. The bank serves customers mainly in its home market of Iceland, where it runs a branch network and offers digital banking, while also serving corporate and investment clients. Its activities span personal banking, corporate and investment banking, and wealth management.
On this site Arion banki hf appears as a stock on the Stockholm Exchange (Sweden), code ARION-SDB, with prices in Swedish kronor (SEK). Our dividend records, which start in 2019, show payments in 2 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Arion banki hf (ARION-SDB) trades on the Stockholm Exchange in Sweden. It last closed at SEK 14.48 on 23 October 2026.
Its price-based Market X-Ray is 71 out of 100 (a strong price profile), ranking 179 of 912 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 3.4% and over the last three months it fell 3.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Stockholm Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 71 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | -0.2% | ||
| From 52-week high | -5.4% | ||
| Momentum | 62 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -3.2% | ||
| 6-month return | 3.4% | ||
| 12-month return, skipping the last month | 4.6% | ||
| Stability (higher is calmer) | 96 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 20.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -13.4% | ||
| Liquidity | 45 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.34M SEK | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 1 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +1.3% |
|---|---|
| 1 month | −1.1% |
| 3 months | −3.2% |
| 6 months | +3.4% |
| 1 year | +3.4% |
| 3 years | +39.0% |
| 5 years | +22.3% |
Signals
| 50-day / 200-day average | 14.59 / 14.51 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.28 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 17 Mar 2022 | ISK 1.0927 |
| 21 Mar 2019 | ISK 0.4085 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Stockholm Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.